RPE derived from human embryonic stem cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RPE derived from human embryonic stem cells, covering 2018-01-31 to 2018-01-31. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Dry Age Related Macular Degeneration Disease With Retinal Pigment Epithelium Derived From Human Embryonic Stem Cells [Phase 1, Phase 2]